NCCN releases new resources to improve quality of life for people with cancer

The National Comprehensive Cancer Network® (NCCN®) is announcing new resources focused on improving quality of life for people with cancer while making sure care planning reflects individual needs and priorities.

RG-6540 by F. Hoffmann-La Roche for Follicular Lymphoma: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

December 31, 2024

2025 could bring some sunshine for health tech startups

After a tough few years, healthcare startups are entering 2025 with cautious optimism. Twelve months ago, early-stage startups faced a funding cliff … Sign up

December 20, 2024

EASD 2024: Novel insights into maternal protection in T1D – Pharmaceutical Technology

At the European Association for the Study of Diabetes (EASD) 2024 conference, results were presented for a meta-analysis, shedding new light on the genetic transmission

September 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.